EntrepreneurialCheck
Hans Gangeskar estimated net worth profile

Hans Gangeskar net worth

Hans Gangeskar Net Worth 2026 (Estimated) · CEO at NURX · YC W16
est. wealth $9.0M

Quick answer

Hans Gangeskar's estimated net worth is $9.0M (range $6.3M – $13.5M) as of 2026. Hans Gangeskar is CEO at NURX. NURX valuation.

Hans Gangeskar is CEO at NURX (YC W16). Independent Entrepreneurial Check model estimate from public YC data.

At a glance

NameHans Gangeskar
RoleCEO
CompanyNURX
YC batchW16
Est. company val$100.0M
Assumed ownership9%
Est. paper wealth / net worth$9.0M
$6.3M – $13.5M
  • Company status: Acquired
  • Region: United States of America
  • Industries: Healthcare, Consumer Health and Wellness
  • Team size: 300
  • Website: https://www.nurx.com/

Who is Hans Gangeskar?

Hans Gangeskar is a co-founder of Nurx (W16), a telemedicine platform focused on making healthcare, particularly birth control and HIV prevention, more accessible and affordable. He is currently the CEO of Overture Life.

Highlights:

  • Co-founded Nurx, a Y Combinator W16 company, to disrupt healthcare delivery
  • Focused on making healthcare more accessible and affordable
  • Currently serves as CEO at Overture Life

About NURX

Nurx is a telemedicine startup focused on increasing access to healthcare, starting with birth control and PrEP services.

FAQ: Hans Gangeskar net worth and NURX valuation

What is Hans Gangeskar's net worth?

Hans Gangeskar's estimated net worth is $9.0M (range $6.3M – $13.5M) as of 2026. Hans Gangeskar is CEO at NURX. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.

What is NURX valuation?

NURX's estimated valuation on Entrepreneurial Check is $100.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.

What is Hans Gangeskar's role?

Hans Gangeskar is CEO at NURX, a Y Combinator-backed startup (batch W16).